Amicus Therapeutics
FOLD
#3908
Rank
A$4.59 B
Marketcap
A$14.90
Share price
-0.50%
Change (1 day)
-1.50%
Change (1 year)

Earnings for Amicus Therapeutics (FOLD)

Earnings in 2025 (TTM): A$6.53 Million

According to Amicus Therapeutics 's latest financial reports the company's current earnings are A$0.59 Billion. In 2024 the company made an earning of -A$43.3 Million, an increase over its 2023 earnings that were of -A$0.23 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Amicus Therapeutics from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$6.53 M-115.09%
2024 -A$43.3 Million-80.84%
2023 -A$0.23 Billion-37.98%
2022 -A$0.37 Billion0.2%
2021 -A$0.37 Billion-11.92%
2020 -A$0.42 Billion-22.94%
2019 -A$0.54 Billion1.95%
2018 -A$0.53 Billion-22.27%
2017 -A$0.68 Billion120.39%
2016 -A$0.31 Billion54.24%
2015 -A$0.2 Billion88.63%
2014 -A$0.11 Billion10.92%
2013 -A$95.07 Million21.36%
2012 -A$78.34 Million8.3%
2011 -A$72.33 Million-14.33%
2010 -A$84.43 Million753.76%
2009 -A$9.89 Million-83.31%
2008 -A$59.25 Million-4.4%
2007 -A$61.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
A$2.86 B 38,117.58%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$1.02 B 13,534.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-A$41.32 Million-650.80%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$14.03 B 187,031.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
-A$0.11 Billion-1,476.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
A$31.38 B 418,322.32%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark